Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

Humanigen could buy IPIX with the change down the back of their corporate sofa - if they wanted to.

But the truth is that literally no real company wants anything to do with IV brilacidin with its highly toxic profile of hypertensive spikes and peripheral neuropathy in the majority of subjects unlucky enough to have the stuff pumped into their veins.

The fact that it actually slowed the recovery of COVID-19 patients while adding that toxicity is merely the icing on the cake.